Author

L. Pepe

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

The AR-ADAR2-PD-L1 Axis as a Prognostic Biomarker System in BCG-Treated High-Grade Papillary Urothelial Carcinoma: A Single-Center Retrospective Cohort Study

: Background: High-grade papillary urothelial carcinoma (HG-PUC) represents a high-risk non-muscle-invasive bladder cancer with frequent recurrence after intravesical Bacillus Calmette-Guérin (BCG) therapy, and reliable prognostic biomarkers remain lacking. The aim of this study was to evaluate the prognostic significa...

Gabriele Ricciardi, M. Ballato, P. Tralongo et al. · Oncology Research · 0 citations

Review Open access Oct 2026

Morphology-Guided Diagnosis of Triple-Negative Breast Carcinoma: From Histopathological Evaluation to Molecular Testing

Background: Triple-negative breast carcinoma (TNBC) comprises several histological entities with different molecular alterations and clinical behaviour. Recognising these entities is important for accurate classification and for choosing appropriate immunohistochemical and molecular tests. Methods: We conducted a narra...

V. Zuccalà, Ida Rizzuto, L. Pepe et al. · Journal of Clinical Medicine · 0 citations

Open access Sep 2026

Association Between Biopsy PD-L1 Combined Positive Score and Pathological Upgrading at Radical Prostatectomy in Grade Group 1 Prostate Cancer: A Retrospective Study

Programmed death-ligand 1 (PD-L1) expression in Grade Group 1 (GG1) prostate carcinoma biopsies has not been established as a marker of pathological upgrading at radical prostatectomy (RP). This two-center retrospective case–control study included 172 men with GG1 carcinoma in the biopsy closest to RP: all 86 patients...

L. Pepe, V. Zuccalà, Ida Rizzuto et al. · International Journal of Mol... · 0 citations